Is the incidence and natural history of breast cancer changed due to hormonal treatment during the lifetime?;L'incidence et l'histoire naturelle des cancers du sein sont-elles modifiées par les traitements hormonaux au cours de la vie ?

Oncologie

Volumn 4, Issue 1, 2002, Pages 2-4

  Sasco, A J ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; INJECTABLE CONTRACEPTIVE AGENT; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

BREAST CANCER; CANCER INCIDENCE; DISEASE COURSE; HORMONE SUBSTITUTION; MENOPAUSE; SHORT SURVEY;

EID: 0036211426     PISSN: 12923818     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (17)

1. Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast cancer
2. Twinship and risk of postmenopausal breast cancer
3. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies
4. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
5. Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. Further follow-up
6. Rethinking breast cancer risk and the environment: The case for the precautionary principle
7. Risque génétique et épidémiologie du cancer du sein
8. Energy balance and cancer: The role of insulin and insulin-like growth factor-I
9. Increased incidence of small and well-differentiated breast tumours in postmenopausal women following hormone-replacement therapy
10. Global cancer statistics in the year 2000
11. Estimates of the worldwide frequency of sixteen major cancers in 1980
12. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
13. Epidemiology of breast cancer: An environmental disease?
14. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk